Rx for Biotech
Rx for Biotech
Podcast Host Chris Leidli
Developing Best-in-Class Radiopharmaceuticals for Cancer Patients
28 minutes Posted Sep 19, 2023 at 12:56 pm.
0:00
28:16
Download MP3
Show notes
Our guests for this podcast episode are the co-founders of Ratio Therapeutics, CEO Jack Hoppin, PhD, and Chief Scientific Officer, John Babich, PhD.
Ratio Therapeutics's mission is to develop best-in-class radiopharmaceuticals for the treatment of cancers.